RecallDepth
Class III Terminated

Quillivant XR methylphenidate HCl, for extended-release oral suspension, 750mg/150 mL total volume (When constituted with 131 mL of water, 25 mg/5 mL (5 mg/mL) when reconstituted, Rx Only, Distributed by Nextwave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc., New York, NY 10017, Manufactured by Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 24478-200-25.

Company
Pfizer Inc.
Recall Initiated
August 4, 2017
Posted
September 27, 2017
Recall Number
D-1164-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
11,790 bottles
Firm Location
New York, NY, United States

Reason for Recall

Failed Dissolution Specifications

Distribution

Nationwide

Lot / Code Info

Lot # 03216047A Exp. 02/18

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class III Drug recalls